Phase I / II Study to Evaluate the Safety, Efficacy, and Novel PET / CT Imaging Biomarkers of CB - 839 in Combination with Panitumumab and
Irinotecan in Patients with Metastatic and Refractory RAS Wildtype Colorectal Cancer
Phase I Clinical Trial of VX - 970 in Combination with the Topoisomerase I Inhibitor
Irinotecan in Patients with Advanced Solid Tumors
In a small, phase I clinical trial, Johns Hopkins Kimmel Cancer Center researchers say they show for the first time that the experimental drug guadecitabine (SGI - 110) is safe in combination with the chemotherapy drug irinotecan and may overcome resistance to
irinotecan in patients with metastatic colorectal cancer.
The investigators used the nanoparticle plus the iRGD to deliver
irinotecan in a robust animal model for pancreatic cancer that closely mimics human disease.
Not exact matches
The study found that carfilzomib and
irinotecan have a potential synergistic effect in SCLC and other Irinotecan - sensitive cancers by allowing normal DNA damage repair and enabling normal cell - cy
irinotecan have a potential synergistic effect
in SCLC and other
Irinotecan - sensitive cancers by allowing normal DNA damage repair and enabling normal cell - cy
Irinotecan - sensitive cancers by allowing normal DNA damage repair and enabling normal cell - cycle death.
The abstract title was: CTC 11 - 001: Phase I study of Carfilzomib (C) +
Irinotecan (I)
in relapsed solid tumors.
Findings were presented at the WCLC are based on the updated results of 12 lung cancer patients enrolled
in the clinical trial with pembro and
irinotecan or gemcitabine with or without vinorelbine or docetaxel.
This causes diarrhea
in up to 90 % of patients who take
irinotecan.
Redinbo and his team now characterize various forms of Beta - glucuronidase produced by different strains of bacteria residing
in the gut, and they show that inhibiting GI bacterial Beta - glucuronidases
in mice does not affect
irinotecan that is circulating
in the blood and is needed to combat cancer.
Here's one example of how this information might be useful for doctors and patients:
Irinotecan is a drug only indicated by the FDA for use
in colon cancer.
Importantly, like cancer cells with other mutations
in the HR repair pathway, CHD1 - depleted prostate cancer cells proved to be hypersensitive to chemotherapeutic drugs causing DNA breaks, such as Mitomycin C,
Irinotecan and PARP inhibitors.
Drugs like fluorouracil, oxaliplatin and
irinotecan work by mimicking and damaging DNA molecules, or inhibiting enzymes involved
in cell and DNA replication, slowing the uncontrolled growth of tumor cells.
Metastatic colorectal cancer, the third deadliest cancer
in the Unites States, is typically treated with two chemotherapy drugs, 5 - Fluorouracil
in combination with either oxaliplatin or
irinotecan.
Lee says the research team will measure the amount of methylation
in patients» cells when they begin their treatment and the presence of genes associated with
irinotecan resistance, among other possible biomarkers.
The current study was based on previous studies
in the laboratory of Nita Ahuja, M.D., director of the Sarcoma and Peritoneal Surface Malignancy Program and professor of surgery at the Johns Hopkins University School of Medicine, which showed that guadecitabine limited the growth of colorectal cancer cell lines when combined with
irinotecan, says Azad.
Scientists leading the new study will also look for biomarkers
in patients that could help determine which of them are most likely to benefit from guadecitabine and
irinotecan.
By reversing this change
in cancer cells, the drug restores cancer cells» vulnerability to drugs such as
irinotecan.
A Multicenter, Randomized, Open - label, 3 - Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs.
Irinotecan / Cetuximab or Infusional 5 - Fluorouracil (5 - FU) / Folinic Acid (FA) /
Irinotecan (FOLFIRI) / Cetuximab with a Safety Lead -
in of Encorafenib + Binimetinib + Cetuximab
in Patients with BRAF V600E - mutant Metastatic Colorectal Cancer
He is the Principal Investigator of international Phase - II, randomized trial of Chimeric 14.18 or Temsirolimus
in combination with
Irinotecan / Temozolomide through Children's Oncology Group (COG).
This is the first study to evaluate the safety and clinical activity of the combination of oral pazopanib, intravenous or oral
irinotecan, and oral temozolomide
in pediatric and young adult patients with relapsed or refractory sarcomas.
One of Dr. Innocentis exemplary achievements is the elucidation of the genetic basis of severe neutropenia
in cancer patients treated with
irinotecan, a poster child for pharmacogenetic.
Irinotecan causes severe diarrhea and neutropenia, a decrease of white blood cells,
in 20 percent to 35 percent of patients.
Ratain, for example, got his start
in the field studying
irinotecan, a drug used to fight colorectal cancer.
Treatment of the Gb3 - expressing gastric carcinoma cell line St3051 with STxB coupled to SN38, the active metabolite of the topoisomerase type I inhibitor
irinotecan, resulted
in > 100-fold increased cytotoxicity, as compared with
irinotecan alone.
Weekly
irinotecan and cisplatin
in advanced non-small cell lung cancer: A phase II multicenter study.
36) Gao K, Lockwood WW, Li J, Lam WL, Li G (2008) Genomic analyses identify gene candidates for acquired
irinotecan resistance
in melanoma cells.
A new animal model of intestinal mucositis induced by the combination of
irinotecan and 5 - fluorouracil
in mice.
Velafermin improves gastrointestinal mucositis following
irinotecan treatment
in tumor - bearing DA rats
Palifermin reduces diarrhea and increases survival following
irinotecan treatment
in tumor - bearing DA rats